ex vivo-expanded HER2-specific T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ex vivo-expanded HER2-specific T cells, covering 2013-05-17 to 2013-05-17. Get the full timeline:
Most recent: Clinical Trial Update: Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer [Phase 1]